Literature DB >> 2355197

Zoonotic potential of giardiasis in domestic ruminants.

A Buret1, N denHollander, P M Wallis, D Befus, M E Olson.   

Abstract

This study was conducted to assess the prevalence and zoonotic potential of giardiasis in domestic ruminants. Prevalence of infection was 17.7% in sheep and 10.4% in cattle and was significantly higher in lambs and calves (35.6% and 27.7%, respectively). Naturally infected lambs released cysts intermittently for months. Giardia trophozoites from sheep had typical claw hammer-shaped median bodies and were successfully cultured in TYI-S-33 medium, and cytosolic, cytoskeletal, and membrane fractions exhibited protein profiles similar to human isolates (WB). Immunoblotting showed that sera from infected sheep recognized human Giardia, sera from patients with giardiasis recognized Giardia from sheep, and in both cases recognition involved antigenic proteins of similar molecular weight. Cyst output and clinical signs in ovine infection resemble human disease and the organisms infecting humans and ruminants are morphologically and antigenically similar. It is postulated that domestic ruminants may be a reservoir for human infection and vice versa, thus classifying giardiasis as a zooanthroponotic disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2355197     DOI: 10.1093/infdis/162.1.231

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Sheep may not be an important zoonotic reservoir for Cryptosporidium and Giardia parasites.

Authors:  Una M Ryan; Caroline Bath; Ian Robertson; Carolyn Read; Aileen Elliot; Linda McInnes; Rebecca Traub; Brown Besier
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 2.  Differentiation of gastrointestinal diseases of calves.

Authors:  C B Navarre; E B Belknap; S E Rowe
Journal:  Vet Clin North Am Food Anim Pract       Date:  2000-03       Impact factor: 3.357

3.  The impact of the Catholic Jubilee in 2000 on infectious diseases. A case-control study of giardiasis, Rome, Italy 2000-2001.

Authors:  A Faustini; C Marinacci; E Fabrizi; M Marangi; O Recchia; R Pica; F Giustini; A La Marca; A Nacci; G Panichi; C A Perucci
Journal:  Epidemiol Infect       Date:  2005-10-28       Impact factor: 2.451

4.  The efficacy of a Giardia lamblia vaccine in kittens.

Authors:  M E Olson; D W Morck; H Ceri
Journal:  Can J Vet Res       Date:  1996-10       Impact factor: 1.310

5.  Prevalence and genotypes of Giardia duodenalis in dairy and beef cattle in farms around Charlottetown, Prince Edward Island, Canada.

Authors:  Fabienne D Uehlinger; Spencer J Greenwood; Ryan O'Handley; J Trenton McClure; Tatjana Coklin; Brent R Dixon; Melvin de Boer; Hester Zwiers; Herman W Barkema
Journal:  Can Vet J       Date:  2011-09       Impact factor: 1.008

6.  The effects of saturated fatty acids on Giardia duodenalis trophozoites in vitro.

Authors:  Paran Rayan; Deborah Stenzel; Pauline Ann McDonnell
Journal:  Parasitol Res       Date:  2005-07-01       Impact factor: 2.289

7.  Determination of Giardia duodenalis genotypes in sheep and goat from Iran.

Authors:  Hedieh Jafari; Mohamad Hossein Razi Jalali; Masoud Seyfi Abad Shapouri; Mohamad Rahim Haji Hajikolaii
Journal:  J Parasit Dis       Date:  2012-11-06

8.  Prevalence of Giardia and Cryptosporidium in beef cows in southern Ontario and in beef calves in southern British Columbia.

Authors:  Tim A McAllister; Merle E Olson; Andy Fletch; Merv Wetzstein; Toby Entz
Journal:  Can Vet J       Date:  2005-01       Impact factor: 1.008

9.  Comparison of genetic groups determined by molecular and immunological analyses of Giardia isolated from animals and humans in Switzerland and Australia.

Authors:  P L Ey; T Bruderer; C Wehrli; P Köhler
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

10.  Degradation of Giardia lamblia cysts in mixed human and swine wastes.

Authors:  M Y Deng; D O Cliver
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.